Navigation Links
DIA Safety Conference To Explore Solutions To Challenges Facing Pharmaocovigilance And Risk Management Strategies
Date:11/19/2009

The Drug Information (DIA) will host its 9th Annual Conference on Contemporary Pharmacovigilance and Risk Management Strategies from January 10-13, 2010 in Washington, DC.

Horsham, PA (Vocus) November 19, 2009 -- The Drug Information (DIA) will host its 9th Annual Conference on Contemporary Pharmacovigilance and Risk Management Strategies from January 10-13, 2010 in Washington, DC.

This comprehensive three-day program will discuss the current complexities and controversies in pharmacovigilance and risk management throughout all phases of development and marketed use, how to optimally utilize epidemiological, clinical pharmacological and other techniques, risk management strategies, and how to create an effective organizational “system.” Session topics will include:

 
  • Latest international regulatory developments
  • How to generate and assess critical safety data during development
  • Compliance with clinical safety and post-marketing pharmacovigilance regulatory requirements in an evolving global environment
  • Recent multinational initiatives under the International Conference on Harmonization (ICH) and Council for International Organizations of Medical Sciences (CIOMS) on Drug Safety Update Reports (DSURs) in premarketing clinical trial safety
  • New approaches to risk management, risk communication, labeling and packaging to optimize medical product benefit while minimizing preventable harm

“Robust drug safety systems and processes and thorough ongoing safety surveillance are more critical than ever in the development and evaluation of the safe use of marketed medicinal products,” says,
Program Committee Member Mariette Boerstoel-Streefland, MD, MBA, MS(epi), Executive Director, Pharmacovigilance/Risk Management, Forest Research Institute, Forest Laboratories Inc. “This conference will provide safety professionals with the latest pharmacovigilance regulatory advances and state-of-the-art risk management strategies."

Pre-conference tutorials on January 9 will focus on:

 
  • Signal Detection, Case Assessment and Data Mining in Pharmacovigilance: Current State of the Art
  • Periodic Safety Update Reports (PSUR): A Guide to the Construction and Analysis of PSURs, ASRs, and DSURs
  • Applied Epidemiology Techniques for Pharmacovigilance Risk Management
  • Applying MedDRA® in Clinical Safety, Pharmacovigilance and Labeling
  • Pharmacovigilance and Risk Management Planning

Register for the 9th Annual Conference on Contemporary Pharmacovigilance and Risk Management Strategies.

About the Drug Information Association (DIA)
A non-profit, neutral, multidisciplinary, global, member-driven association, DIA serves more than 30,000 professionals involved in the biopharmaceutical industry, academia, research organizations and governmental bodies worldwide. Through its domestic and international meetings, training courses, workshops and webinars, DIA provides a neutral global forum for the exchange of information critical to the advancement of drug development and medical product lifecycle management. DIA is led by its volunteer Board of Directors and executive management team, has headquarters in Horsham, PA, USA, and offices in Basel, Switzerland, Tokyo, Japan, Mumbai, India, and Beijing, China. For more information, visit www.diahome.org or call 215-442-6100.

Contact:
Joe Krasowski
DIA
215-293-5812

###

Read the full story at http://www.prweb.com/releases/DIA/Safety_Conference/prweb3230364.htm.


'/>"/>
Source: PRWeb
Copyright©2009 Vocus, Inc.
All rights reserved  

Related medicine news :

1. Respirators and H1N1 Information Distributed to Registered Nurses at Sacred Heart Medical Center Out of Concern for Nurse and Patient Safety
2. National Patient Safety Foundation Supports Mandatory Flu Vaccinations for Healthcare Workers
3. Houston Dermatologists to Round Up for Sun Safety at World-Class LPGA Tour Championship
4. Dairy Groups Urge Senators to Include Raw Milk Facilities in Food Safety Regulations
5. Walking hazard: Cell-phone use -- but not music -- reduces pedestrian safety
6. XOLAIR Safety Study Continues to 2012 Despite Increased Rate of Occurrence of Heart Problems, Onder Law Firm Offers Free XOLAIR Case Review
7. FDA Questions Safety of Caffeinated Alcoholic Drinks
8. Centerplate and the Capital Improvement Board Investigating Food Safety Violations at Lucas Oil Stadium to Ensure Highest Standards Achieved and Operational Excellence
9. New Polls, Reports Highlight The Need To Update The U.S. Food Safety System And To Make Our Food Safe For The Holidays
10. New Research Center to Focus on Cardiac Safety and Innovation
11. New research center to focus on cardiac safety and innovation
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
DIA Safety Conference To Explore Solutions To Challenges Facing Pharmaocovigilance And Risk Management Strategies
(Date:12/2/2016)... Raleigh, NC (PRWEB) , ... December 02, 2016 , ... ... the Open Enrollment Period (or Annual Election Period), is ending December 7th. Currently-enrolled Medicare ... plan (Part C) or prescription drug plan (Part D) need to make changes during ...
(Date:12/2/2016)... (PRWEB) , ... December 02, 2016 , ... ... inspirational interview of two ostomy patients, standing as living proof that attitude and ... from digestive diseases and issues that spike around the holidays. This campaign will ...
(Date:12/2/2016)... , ... December 02, 2016 , ... ... of "Cardiovascular Health" in USA Today, which covers the innovative treatments, therapeutic technologies, ... while maintaining fulfilling lives. “We are prolonging life 6 years in the last ...
(Date:12/2/2016)... OH (PRWEB) , ... December 02, 2016 , ... ... of veterinarian diagnostic imaging systems and the first company to offer ... With a Heart at their tradeshow booth # 941 for the American Association ...
(Date:12/2/2016)... ... 02, 2016 , ... Yisrayl Hawkins, at The House of Yahweh in Abilene, ... into Bible Prophecy. Yisrayl says this generation, known as the Last Generation, started in ... the details line up exactly with Bible Prophecy – a protected way for those ...
Breaking Medicine News(10 mins):
(Date:12/2/2016)... , Dec. 1, 2016  Today, Simpson Healthcare Executives, ... honor of being selected as winners of multiple awards ... Executives Website at the PLATINUM level, Blue Zones Menu ... at the GOLD Level, and our proprietary 3ConneX Platform ... Simpson Healthcare Executives, we are excited to showcase our ...
(Date:12/2/2016)... BRUSSELS , Dec. 2, 2016  UCB is pleased to ... presentation at the upcoming 70 th American Epilepsy Society ... Houston, TX , USA. 1-12 ... safety and efficacy profile of VIMPAT ® (lacosamide) CV ... also share findings on the current state of the union ...
(Date:12/2/2016)... Dec. 2, 2016 Allergan plc (NYSE: ... information on its previously announced Accelerated Share Repurchase (ASR) Program. ... ... As previously announced, the Company entered into a ... the Company will repurchase $10 billion of its ordinary shares. ...
Breaking Medicine Technology: